Literature DB >> 30174874

Outcomes of patients undergoing surgery for thymic carcinoma: a single-center experience.

Yusuke Nabe1, Yoshinobu Ichiki1, Yukiko Fukuichi1, Masataka Mori1, Yohei Honda1, Masatoshi Kanayama1, Akihiro Taira1, Shinji Shinohara1, Taiji Kuwata1, Masaru Takenaka1, Yasuhiro Chikaishi1, Soichi Oka1, Ayako Hirai1, Yuko Tashima1, Koji Kuroda1, Naoko Imanishi1, Kazue Yoneda1, Fumihiro Tanaka1.   

Abstract

BACKGROUND: Thymic carcinoma is uncommon, presents locally at an advanced stage, and behaves aggressively. The optimum treatment for advanced thymic carcinoma is controversial. We retrospectively reviewed our institutional experience with patients with thymic carcinoma.
METHODS: We analyzed the clinical data of six patients who underwent total thymectomy for thymic carcinoma at our institution from 2006 to 2016. Variables analyzed included sex, age, histological classification, Masaoka staging, postoperative treatment, and recurrence.
RESULTS: The clinical characteristics of the six patients with thymic carcinoma (median age, 56 years; five men and one woman) were as follows: squamous cell carcinoma (n=5); sarcomatoid carcinoma (n=1); Masaoka stages II (n=1), III (n=2), IVa (n=1), and IVb (n=2). Four patients underwent combined pulmonary resection (66.7%) as a component of en bloc resection due to suspicion of pulmonary invasion. Four patients (66.7%) received postoperative therapy, and complete resection was achieved for four patients. There were no perioperative deaths. One patient experienced a recurrence.
CONCLUSIONS: Complete resection for thymic cancer improved the prognosis of our patients, indicating that robust studies will be required to confirm our findings.

Entities:  

Keywords:  Thymic carcinoma; oncology; surgery

Year:  2018        PMID: 30174874      PMCID: PMC6106022          DOI: 10.21037/jtd.2018.06.36

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  11 in total

1.  Thymic carcinoma: is it a separate entity? From molecular to clinical evidence.

Authors:  Alexander Marx; Ralf Rieker; Alper Toker; Florian Länger; Philipp Ströbel
Journal:  Thorac Surg Clin       Date:  2011-02       Impact factor: 1.750

2.  Thymic carcinoma: 30 cases at a single institution.

Authors:  Motoki Yano; Hidefumi Sasaki; Tomoki Yokoyama; Haruhiro Yukiue; Osamu Kawano; Sadao Suzuki; Yoshitaka Fujii
Journal:  J Thorac Oncol       Date:  2008-03       Impact factor: 15.609

3.  Thymic carcinoma outcomes and prognosis: results of an international analysis.

Authors:  Usman Ahmad; Xiaopan Yao; Frank Detterbeck; James Huang; Alberto Antonicelli; Pier Luigi Filosso; Enrico Ruffini; William Travis; David R Jones; Yilei Zhan; Marco Lucchi; Andreas Rimner
Journal:  J Thorac Cardiovasc Surg       Date:  2014-10-05       Impact factor: 5.209

4.  Complete Resection of Thymic Sarcomatoid Carcinoma Through Total Aortic Arch Replacement.

Authors:  Soichi Oka; Akihiro Taira; Shuichi Shinohara; Taiji Kuwata; Masaru Takenaka; Yasuhiro Chikaishi; Ayako Hirai; Hidetaka Uramoto; Yosuke Nishimura; Fumihiro Tanaka
Journal:  Ann Thorac Surg       Date:  2016-12       Impact factor: 4.330

5.  Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients.

Authors:  Benny Weksler; Rajeev Dhupar; Vishal Parikh; Katie S Nason; Arjun Pennathur; Peter F Ferson
Journal:  Ann Thorac Surg       Date:  2012-11-07       Impact factor: 4.330

6.  Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.

Authors:  Tomoyuki Hishida; Shogo Nomura; Motoki Yano; Hisao Asamura; Motohiro Yamashita; Yasuhisa Ohde; Keishi Kondo; Hiroshi Date; Meinoshin Okumura; Kanji Nagai
Journal:  Eur J Cardiothorac Surg       Date:  2015-06-26       Impact factor: 4.191

7.  Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.

Authors:  Kazuya Kondo; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

8.  Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience.

Authors:  Francisco J Hernandez-Ilizaliturri; Dongfeng Tan; David Cipolla; Gregory Connolly; George Debb; Nithya Ramnath
Journal:  Am J Clin Oncol       Date:  2004-02       Impact factor: 2.339

9.  Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database.

Authors:  Enrico Ruffini; Frank Detterbeck; Dirk Van Raemdonck; Gaetano Rocco; Pascal Thomas; Walter Weder; Alessandro Brunelli; Francesco Guerrera; Shaf Keshavjee; Nasser Altorki; Jan Schützner; Alex Arame; Lorenzo Spaggiari; Eric Lim; Alper Toker; Federico Venuta
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

10.  Thymic carcinoma: involvement of great vessels indicates poor prognosis.

Authors:  Yau-Lin Tseng; Shan-Tair Wang; Ming-Ho Wu; Mu-Yen Lin; Wu-Wei Lai; Fen-Fen Cheng
Journal:  Ann Thorac Surg       Date:  2003-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.